These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7423154)
1. [Fluorouracil, mitomycin-C and adriamycin in the treatment of metastasizing gastrointestinal adenocarcinomas]. Späti B; Jungi WF; Mayr AC; Hammer B; Senn HJ Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1076-8. PubMed ID: 7423154 [TBL] [Abstract][Full Text] [Related]
2. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394 [TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer. Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Gibson MK; Holcroft CA; Kvols LK; Haller D Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma. Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study]. Burk K; Gropp C; Rodeck G Urologe A; 1983 Sep; 22 Suppl():347-9. PubMed ID: 6415885 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM). Oster MW; Gray R; Panasci L; Perry MC Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer. De Jager RL; Magill GB; Golbey RB; Krakoff IH Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970 [No Abstract] [Full Text] [Related]
9. Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study. Steffensrud S; Erichsen H; Røysland P; Halvorsen TB; Klepp R; Klepp O; Wünsch E; Petersen H Scand J Gastroenterol; 1984 Oct; 19(7):909-15. PubMed ID: 6085189 [TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate. Bruckner HW; Deppe G Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531 [TBL] [Abstract][Full Text] [Related]
11. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers. Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403 [TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM). Haim N; Cohen Y; Honigman J; Robinson E Cancer Chemother Pharmacol; 1982; 8(3):277-80. PubMed ID: 6897021 [TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C. Krauss S; Sonoda T; Solomon A Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355 [No Abstract] [Full Text] [Related]
14. Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. Hartmann JT; Kanz L; Bokemeyer C Anticancer Res; 2000; 20(2B):1177-82. PubMed ID: 10810418 [TBL] [Abstract][Full Text] [Related]
15. Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules. Lam WK; So SY; Ip M; Yu DY Cancer Chemother Pharmacol; 1985; 14(3):282-3. PubMed ID: 3922641 [TBL] [Abstract][Full Text] [Related]
16. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]. Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022 [TBL] [Abstract][Full Text] [Related]
17. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature]. Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657 [TBL] [Abstract][Full Text] [Related]
18. [5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases)]. Vinhafs JC; Ferreira AJ Hospital (Rio J); 1967 Feb; 71(2):453-74. PubMed ID: 5302398 [No Abstract] [Full Text] [Related]
19. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas. Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890 [TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of gastrointestinal cancer (author's transl)]. Gropp C; Havemann K Z Gastroenterol; 1978 Oct; 16(10):609-15. PubMed ID: 151993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]